Mid-budget productions, those without the safety net of studio support, are finding it harder to get the cameras turning again. But some of the resourceful film-makers at the low-budget end of the spectrum, accustomed to having to solve problems on a daily basis, are already working around the inconvenience of the pandemic. Producer Laurie Cook, whose credits include Ron Scalpello’s Pressure and several movies by genre director Christopher Smith, has a film scheduled to start shooting in early autumn. With one location, two cast members and a scaled-back crew, it’s a picture better suited than many for the challenge posed by Covid-19. “What we plan to do,” she says, “is isolate the two leads, the director and a crew member – someone with makeup abilities, who will also be doing costume checks – for the last two weeks of prep. They will be tested for coronavirus weekly. They’re going to be their own bubble.” … [Read more...] about The future of film: can cinema survive Covid-19?
Amc clinical results
“We went into COVID with people marginally housed, homeless, in overcrowding living situations, with no living wage, no paid leave, no sick leave,” Watkins-Tartt said. “It’s not one thing, it’s not two things, it’s a lot of things all coming together to make this a very difficult thing to prevent in some communities, and also difficult to recover from in those same communities.” … [Read more...] about Coronavirus started as a ‘great equalizer.’ Now it is defined by disparities in income and race, Bay Area data show
Peter Kremsner: The first phase can be successfully accomplished here. At the moment, the only countries in the EU where efficacy could be tested are Sweden and perhaps Portugal. We cannot start the third phase of the research, during which we can see the effectiveness of the drug if the situation remains at the current level and the number of patients continues to decrease. … [Read more...] about German Coronavirus Vaccine Drug ‘Very Well Tolerated’ in Human Tests
Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe COVID-19 complications. The DCGI nod for the repurposed drug is based on results from the successful conclusion of a randomised, controlled clinical trial at multiple hospitals in Mumbai and New Delhi. … [Read more...] about Biocon’s psoriasis drug gets DCGI nod for use in COVID-19 patients
As coronavirus cases spike up in hotbeds across the country, India's premier vaccine maker based out of Pune, Serum Institute of India (SII) said that they are expecting a timeline of atleast six months before we see one of their vaccines being deployed for public use. Serum Institute of India has partnered with the University of Oxford to speed up the development of a safe and affordable Coronavirus vaccine. The private company has already ramped up trials and early-stage testing so that early prototypes of a "safe" vaccine would be made available as soon as possible. Globally, COVID-19 cases have breached 12 million mark, with over 5,48,000 casualties reported. The company's CEO issued a statement at a recent press conference adding that while work is underway, the researchers were in no rush and wanted to produce a safe and effective vaccine. “Once we are confident of a safe and good vaccine for India and the world. We will certainly announce it when we are licensed by the … [Read more...] about Coronavirus India vaccine: “Safe” COVID-19 vaccine six months away, says Serum Institute of India